J. Glossmann

发表

p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status.

A. Hölscher, S. Baldus, H. Dienes, 2001, Scandinavian journal of gastroenterology.

Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis

M. Hallek, K. Kreuzer, J. Glossmann, 2014, Mycoses.

Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach

J. Gaertner, M. Hallek, J. Wolf, 2011, Supportive Care in Cancer.

Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)

P. Dahm, G. Gartlehner, J. Glossmann, 2017 .

[Conjunctival melanoma : Standard operating procedures in diagnosis, treatment and follow-up care].

S. Leyvraz, J. Glossmann, N. Skoetz, 2018, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas

S. Baldus, H. Dienes, S. Mönig, 1998, International journal of cancer.

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant

J. Glossmann, P. Borchmann, A. Engert, 2014, Leukemia & lymphoma.

Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.

H. Eich, R. Müller, V. Diehl, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease – Results of the German Hodgkin Study Group

V. Diehl, J. Franklin, M. Sieber, 2005, Leukemia & lymphoma.

New treatments for Hodgkin’s disease

V. Diehl, J. Glossmann, A. Josting, 2002, Current treatment options in oncology.

Cancer Care: New Value Chains Challenge German Hospital Structures—A Comprehensive Cancer Center Perspective

J. Wolf, M. Hallek, J. Glossmann, 2016 .

Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma

V. Diehl, J. Glossmann, L. Nogova, 2005, Annals of Hematology.

Konjunktivales Melanom

S. Leyvraz, J. Glossmann, N. Skoetz, 2018, Der Ophthalmologe.

Thalidomide for systemic capillary leak syndrome.

V. Diehl, J. Glossmann, A. Josting, 2003, The American journal of medicine.

The use of statins in hematopoietic stem cell transplantation.

J. Glossmann, A. Shimabukuro-Vornhagen, C. Scheid, 2009, Current stem cell research & therapy.

Extramedullar Acute Myeloid Leukemia (Granulocytic Sarcoma) with Arm Paresis, Maculopapular Exanthema and Organ Involvement

V. Diehl, J. Glossmann, C. Wickenhauser, 2003, Leukemia & lymphoma.

Recommending early integration of palliative care — does it work?

M. Hellmich, J. Gaertner, M. Hallek, 2012, Supportive Care in Cancer.

Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole

J. Glossmann, H. Seifert, S. Padosch, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Increased Galectin-3 Expression in Gastric Cancer: Correlations with Histopathological Subtypes, Galactosylated Antigens and Tumor Cell Proliferation

A. Hölscher, S. Baldus, H. Dienes, 2000, Tumor Biology.

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).

P. Dahm, G. Gartlehner, J. Glossmann, 2018, The Cochrane database of systematic reviews.

Immunoreactivity of Monoclonal Antibody BW835 Represents a Marker of Progression and Prognosis in Early Gastric Cancer

A. Hölscher, S. Baldus, H. Dienes, 2001, Oncology.

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy—results of a randomized trial

G. Wassmer, V. Diehl, B. Dörken, 2003, Annals of Hematology.

Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.

V. Diehl, J. Franklin, J. Glossmann, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.

V. Diehl, J. Raemaekers, N. Schmitz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

U. Paulus, J. Glossmann, A. Engert, 2002, Annals of Hematology.

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

V. Diehl, B. Dörken, M. Sieber, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.

V. Diehl, B. Dörken, Y. Ko, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective

T. Zander, J. Wolf, M. Hallek, 2017, European journal of haematology.

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

V. Diehl, J. Glossmann, A. Engert, 2006, Annals of Hematology.

Specifying WHO recommendation: moving toward disease-specific guidelines.

J. Gaertner, M. Hallek, J. Wolf, 2010, Journal of palliative medicine.

Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole

D. Stippel, J. Glossmann, H. Seifert, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy—results of a randomized trial

G. Wassmer, B. Dörken, Y. Ko, 2003, Annals of Hematology.

["Lean management" in hospitals: potentials and limitations].

O. Schliebusch, J. Glossmann, R. Walshe, 2000, Medizinische Klinik.

Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.

V. Diehl, J. Raemaekers, N. Schmitz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).

M. Sieber, J. Glossmann, B. Metzner, 2004 .